BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7932719)

  • 1. Interaction between tumour necrosis factor alpha ribozyme and cellular proteins. Involvement in ribozyme stability and activity.
    Sioud M
    J Mol Biol; 1994 Oct; 242(5):619-29. PubMed ID: 7932719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
    Sioud M; Jespersen L
    J Mol Biol; 1996 Apr; 257(4):775-89. PubMed ID: 8636981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA.
    Wang E; Ma WJ; Aghajanian C; Spriggs DR
    Cancer Res; 1997 Dec; 57(23):5426-33. PubMed ID: 9393771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of macrophage TNF-alpha expression by in vivo ribozyme treatment.
    Kisich KO; Malone RW; Feldstein PA; Erickson KL
    J Immunol; 1999 Aug; 163(4):2008-16. PubMed ID: 10438938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the helix 2 region for the cis-cleaving and trans-cleaving activities of hepatitis delta virus ribozymes.
    Lee CB; Lai YC; Ping YH; Huang ZS; Lin JY; Wu HN
    Biochemistry; 1996 Sep; 35(38):12303-12. PubMed ID: 8823164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes that function in the TNF-alpha-mediated apoptotic pathway using randomized hybrid ribozyme libraries.
    Kawasaki H; Onuki R; Suyama E; Taira K
    Nat Biotechnol; 2002 Apr; 20(4):376-80. PubMed ID: 11923844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by peritoneal cells in vitro and in vivo.
    Sioud M
    Eur J Immunol; 1996 May; 26(5):1026-31. PubMed ID: 8647163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
    MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
    Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozyme recognition of RNA by tertiary interactions with specific ribose 2'-OH groups.
    Pyle AM; Cech TR
    Nature; 1991 Apr; 350(6319):628-31. PubMed ID: 1708111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific interaction between the hepatitis delta virus RNA and glyceraldehyde 3-phosphate dehydrogenase: an enhancement on ribozyme catalysis.
    Lin SS; Chang SC; Wang YH; Sun CY; Chang MF
    Virology; 2000 May; 271(1):46-57. PubMed ID: 10814569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the RNA chaperone activity of recombinant human tumor necrosis factor alpha in vitro.
    Cao G; Yang G; Liu Z; Liu X; Zhang J; Zhang D; Liu N; Ding H; Fan M; Shen B; Shao N
    Biochem Biophys Res Commun; 2005 Mar; 328(2):573-9. PubMed ID: 15694386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between RNA molecules of a two-componet trans-analog of antigenomic HDV-ribozyme].
    Alekseenkova VA; Belianko TI; Lukin MA; Savochkina LP; Bibilashvili RSh
    Mol Biol (Mosk); 2006; 40(1):90-9. PubMed ID: 16523696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorothiolate ribozyme against the conserved sequence in V3 loop of HIV-1.
    Zhang X; Yamada R; Shimayama T; Imada K; Uchiyama T; Hattori T
    Biochem Biophys Res Commun; 1996 Dec; 229(2):466-71. PubMed ID: 8954921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene targeting by ribozyme against TNF-alpha mRNA inhibits autoimmune arthritis.
    Kumar R; Dammai V; Yadava PK; Kleinau S
    Gene Ther; 2005 Oct; 12(20):1486-93. PubMed ID: 16034454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-RNA and RNA-DNA ligation with the sTobRV(+) hammerhead ribozyme.
    Tokumoto Y; Saigo K
    Nucleic Acids Symp Ser; 1992; (27):21-2. PubMed ID: 1283908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.